Oracle Corp's market capitalization of $181,882,420,520 is ahead of 99.01% of US-listed equities.
ORCL's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 714.9 -- higher than 94.35% of US-listed equities with positive expected earnings growth.
In terms of volatility of its share price, ORCL is more volatile than just 5.02% of stocks we're observing.
Stocks with similar financial metrics, market capitalization, and price volatility to Oracle Corp are CSCO, LLY, CRM, NVO, and AVGO.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. The company was founded in 1977 and is based in Redwood City, California.
ORCL Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Oracle Corp. To summarize, we found that Oracle Corp ranked in the 35th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for ORCL, they are:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 73. Its equity weight surpasses that of just 14.76% of free cash flow generating stocks in the Technology sector.
Its compound free cash flow growth rate, as measured over the past 5.74 years, is -0.02% -- higher than only 21.68% of stocks in our DCF forecasting set.
Oracle Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 10.42% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Oracle Corp? See MEI, ACIW, NOVT, RMNI, and TEAM.
A coalition made up of health and technology companies which include both Microsoft Corporation (NASDAQ: MSFT), Salesforce.com Inc (NYSE: CRM), and Oracle Corporation (NYSE: ORCL) is working on developing a digital passport for COVID-19 vaccines.What Happened: The Vaccine Credential Initiative also includes MITRE, Mayo Clinic, Evernorth, The Commons Project Foundation, and CARIN Alliance among others, as per a statement issued Thursday. "As the world begins to recover from the pandemic, having electronic access to vaccination, testing, and other medical records will be vital to resuming travel and more," said Mike Sicilia, executive vice president of Oracle's global business units. The group anticipates that a trustworthy, traceable, verifiable, and universally recognized digital record...